Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-03-Speech-2-477-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-07-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Anti-Counterfeiting Trade Agreement between the EU and its Member States, Australia, Canada, Japan, the Republic of Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland and the USA (debate)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20120703.21.2-477-000"2
lpv:hasSubsequent	lp_eu:2012-07-03-Speech-2-478-0002
lpv:speaker	lp:Ska Keller2
lpv:spokenAs	member; G/EFA (2009-07-14--2014-06-30)3 member; INTA (2012-05-24--2014-06-30)3 member; Delegation to the EU-Turkey Joint Parliamentary Committee (2009-09-16--2014-06-30)3 unknown; Bündnis 90/Die Grünen (2009-07-14--2014-06-30)3 substitute; LIBE (2012-01-19--2014-06-30)3 substitute; Delegation to the EU-Mexico Joint Parliamentary Committee (2012-02-13--2014-06-30)3
lpv:translated text	"Mr President, the Anti-Counterfeiting Trade Agreement (ACTA) does not protect us against dangerous counterfeit medicines with ingredients that have been manipulated, because ACTA is not concerned with the content of the pills, but only with the packaging. Instead, ACTA makes accessing effective generic medicines more difficult. The people whose lives and health depend on affordable generics have not been asked whether they would like to vote in favour of ACTA or whether they prefer not to have it at all. If we take the interests of these people into account in tomorrow’s vote, then there is only one route for us to take. We must vote against ACTA."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph